TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) Stock Profile — Insider Trades & Financials

Smart-Money SignalDistribution · 34/100— Insiders are net sellers over 90 days (-$15.5M, 5 sales vs 0 buys)

Revenue$4.1B

Net Income-$576.0M

EPS$-0.18

Gross Margin52.0%

Market Cap$48.2B

Price Performance

Historical data including institutional events

Company Profile

Richard Francis

CEO & Executive Director

Teva Pharmaceutical Industries Ltd. is an Israeli multinational pharmaceutical company. Teva specializes primarily in generic drugs, but other business interests include branded-drugs, active pharmaceutical ingredients (APIs) and, to a lesser extent, contract manufacturing services and an out-licensing platform.

Founded: 1901
Employees: 43,000
Headquarters: TEL AVIV, Israel
Website: www.tevapharm.com

Peer ComparisonRevenue ($B)

▾

Loading company sections...

Smart-Money SignalDistribution · 34/100— Insiders are net sellers over 90 days (-$15.5M, 5 sales vs 0 buys)

Revenue$4.1B

Net Income-$576.0M

EPS$-0.18

Gross Margin52.0%

Market Cap$48.2B

Price Performance

Historical data including institutional events

Company Profile

Richard Francis

CEO & Executive Director

Founded: 1901
Employees: 43,000
Headquarters: TEL AVIV, Israel
Website: www.tevapharm.com

Peer ComparisonRevenue ($B)

▾

Smart-Money Signal

90-DAY POSTURE

34/ 100

DISTRIBUTION

Insiders are net sellers over 90 days (-$15.5M, 5 sales vs 0 buys). Smart-money posture skews to distribution.

Insider flow · 90d-$15.5M

Congress flow · 90dno activity

10b5-1 share7% planned

Cluster selling5 officers

Price vs 52w100% of high

Cross-Section Event Timeline

INSIDERS · CONGRESS · EARNINGS

INSIDER SELLEric A. Hughes (See "Remarks") SELL TEVAAug 3, 2026

INSIDER EXERCISE / CONVERSIONEric A. Hughes (See "Remarks") EXERCISE / CONVERSION TEVAAug 3, 2026

INSIDER SELLTal Zvi Zaks (Director) SELL TEVAAug 5, 2026

INSIDER SELLEvan Lippman (EVP, Business Development) SELL TEVAAug 17, 2026

INSIDER SELLRonit Satchi-Fainaro (Director) SELL TEVAAug 21, 2026

INSIDER SELLAmir Weiss (Chief Accounting Officer) SELL TEVAAug 21, 2026

INSIDER EXERCISE / CONVERSIONAmir Weiss (Chief Accounting Officer) EXERCISE / CONVERSION TEVAAug 21, 2026

INSIDER SELLAmir Weiss (Chief Accounting Officer) SELL TEVAAug 21, 2026

INSIDER SELLRoberto Mignone (Director) SELL TEVASep 18, 2026

INSIDER EXERCISE / CONVERSIONBrian Savage (Interim Chief Legal Officer) EXERCISE / CONVERSION TEVASep 18, 2026

INSIDER SELLBrian Savage (Interim Chief Legal Officer) SELL TEVASep 18, 2026

⚡

Core Efficiency

ROE?

-7.43%

ROA?

-1.45%

D/E Ratio?

4.14

Op. Margin?

-5.58%

📊

Profitability Ratios

Net Margin?

-13.91%

Current Ratio?

0.88

Loading comparison...

Earnings Calendar

Filing history and next expected filing date

Next Expected Filing

Nov 3, 2026 (in 21 days)

Quarterly Report (10-Q) — Based on filing pattern

Nov 3, 2026

Predicted10-Q

Jul 29, 2026

10-QQ2 202629d after period end

Apr 29, 2026

10-QQ1 202629d after period end

Feb 3, 2026

10-KQ4 202534d after period end

Feb 3, 2026

10-KFY 202534d after period end

Nov 5, 2025

10-QQ3 202536d after period end

Jul 30, 2025

10-QQ2 202530d after period end

May 7, 2025

10-QQ1 202537d after period end

Feb 5, 2025

10-KQ4 202436d after period end

Data Freshness

Financial Data

2mo ago

Latest filing: 2026-07-29

SEC Metadata

2mo ago

Latest filing: 2026-07-29

Loading company sections...

TEVA PHARMACEUTICAL INDUSTRIES LTD

Price Performance

Company Profile

TEVA PHARMACEUTICAL INDUSTRIES LTD

Price Performance

Company Profile

Core Efficiency

Profitability Ratios

Earnings Calendar

Data Freshness

Recent Insider Trades

Core Efficiency

Profitability Ratios

Earnings Calendar

Data Freshness

Recent Insider Trades

TEVA PHARMACEUTICAL INDUSTRIES LTD

Price Performance

Company Profile

The morning brief, before the bell.

TEVA PHARMACEUTICAL INDUSTRIES LTD

Price Performance

Company Profile

Core Efficiency

Profitability Ratios

Earnings Calendar

Data Freshness

Recent Insider Trades

Core Efficiency

Profitability Ratios

Earnings Calendar

Data Freshness

Recent Insider Trades